Talbot Financial’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$15.7M Buy
200,207
+7,241
+4% +$584K 1.15% 29
2026
Q1
$16.7M Buy
192,966
+4,147
+2% +$397K 1.41% 29
2025
Q4
$18.1M Sell
188,819
-1,903
-1% -$185K 1.49% 22
2025
Q3
$18.2M Buy
190,722
+12,716
+7% +$1.17M 1.54% 26
2025
Q2
$15.5M Buy
178,006
+43,279
+32% +$3.67M 1.47% 26
2025
Q1
$12.1M Buy
134,727
+1,274
+1% +$114K 1.52% 26
2024
Q4
$10.7M Buy
133,453
+8,031
+6% +$695K 1.27% 33
2024
Q3
$11.3M Buy
125,422
+4,371
+4% +$368K 1.37% 29
2024
Q2
$9.53M Buy
121,051
+8,029
+7% +$658K 1.23% 30
2024
Q1
$9.85M Buy
113,022
+9,642
+9% +$823K 1.32% 30
2023
Q4
$8.52M Buy
103,380
+6,601
+7% +$503K 1.28% 33
2023
Q3
$7.58M Buy
96,779
+5,399
+6% +$452K 1.32% 34
2023
Q2
$8.05M Buy
+91,380
New +$7.87M 1.37% 31

Other funds holding MDT

Talbot Financial's MDT Position: Q2 2026 in Review

Talbot Financial increased its Medtronic (MDT) stake by 3.8% in Q2 2026, buying an estimated $584K and bringing the position to 200,207 shares worth $15.7M. The position accounts for 1.15% of the portfolio, ranked #29.

Talbot Financial first reported a position in MDT in Q2 2023 and has held it in 13 quarters since. The position peaked at $18.2M in Q3 2025. 372 funds tracked by Wall St. Rank hold MDT as of Q2 2026.

  • Talbot Financial held 200,207 shares of Medtronic worth $15.7M as of Q2 2026.
  • Talbot Financial bought 7,241 Medtronic shares in Q2 2026, an estimated $584K.
  • Medtronic made up 1.15% of Talbot Financial's portfolio in Q2 2026, its #29 holding.
  • Talbot Financial first reported a position in Medtronic in Q2 2023 and has held it in 13 quarters since.
  • Talbot Financial's Medtronic position peaked at $18.2M in Q3 2025.
  • 372 funds tracked by Wall St. Rank held Medtronic as of Q2 2026.

Based on Talbot Financial's 13F filing for Q2 2026, filed 14 Jul 2026.